A detailed history of Daiwa Securities Group Inc. transactions in Precigen, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 708 shares of PGEN stock, worth $651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
708
Previous 708 -0.0%
Holding current value
$651
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

BUY
$4.99 - $6.55 $1,531 - $2,010
307 Added 76.56%
708 $4,000
Q1 2021

May 03, 2021

SELL
$6.74 - $10.95 $648,037 - $1.05 Million
-96,148 Reduced 99.58%
401 $3,000
Q4 2020

Feb 04, 2021

SELL
$3.75 - $10.56 $2,508 - $7,064
-669 Reduced 0.69%
96,549 $985,000
Q3 2020

Nov 02, 2020

BUY
$3.5 - $6.2 $162,050 - $287,060
46,300 Added 90.93%
97,218 $340,000
Q2 2020

Aug 11, 2020

SELL
$2.16 - $5.46 $259,200 - $655,200
-120,000 Reduced 70.21%
50,918 $252,000
Q1 2020

May 14, 2020

BUY
$1.46 - $7.19 $249,540 - $1.23 Million
170,918 New
170,918 $581,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $191M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.